Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-26 @ 3:54 AM
Study NCT ID:
NCT05133518
Status:
COMPLETED
Last Update Posted:
2022-12-19
First Post:
2021-11-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)
Sponsor:
Melt Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-03
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-12
First Submit QC Date:
None
Study First Post Date:
2021-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-15
Last Update Post Date:
2022-12-19
Last Update Post Date Type:
ACTUAL